Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

You are here: Home / Statistics / Comparative statistics by registry

Comparative statistics by cancer registry

Table2b: Number and proportion of cases by vital status and median follow-up (in months) by site

(Incheon, Korea, 1997-2001 cases followed-up until 2002)

Click on cancer site (ICD-10 code) for comparison

Site	ICD-10	Total included	Dead		Alive		Complete FU		Median FU (in months)
Site	ICD-10	Total included	No.	%	No.	%	No.	%	Median FU (in months)
C01-02	Tongue	50	26	52.0	24	48.0	50	100.0	23.2
C03-06	Oral cavity	64	26	40.6	38	59.4	64	100.0	24.4
C07-08	Salivary gland	49	15	30.6	34	69.4	49	100.0	37.6
C09	Tonsil	27	14	51.9	13	48.1	27	100.0	18.9
C11	Nasopharynx	74	32	43.2	42	56.8	74	100.0	24.7
C12-13	Hypopharynx	51	33	64.7	18	35.3	51	100.0	18.5
C15	Oesophagus	304	226	74.3	78	25.7	304	100.0	10.4
C16	Stomach	4293	2099	48.9	2194	51.1	4293	100.0	19.9
C17	Small intestine	81	47	58.0	34	42.0	81	100.0	14.1
C18	Colon	1120	448	40.0	672	60.0	1120	100.0	24.2
C19-20	Rectum	1122	434	38.7	688	61.3	1122	100.0	24.9
C22	Liver	2328	1816	78.0	512	22.0	2328	100.0	5.6
C23-24	Gall bladder	506	377	74.5	129	25.5	506	100.0	9.4
C25	Pancreas	518	440	84.9	78	15.1	518	100.0	4.1
C30-31	Nose/Sinuses	50	17	34.0	33	66.0	50	100.0	31.2
C32	Larynx	222	91	41.0	131	59.0	222	100.0	23.9
C33-34	Lung	2566	2002	78.0	564	22.0	2566	100.0	7.5
C37-38	Other thoracic organs	56	29	51.8	27	48.2	56	100.0	18.3
C40-41	Bone	104	33	31.7	71	68.3	104	100.0	35.8
C43	Melanoma skin	45	15	33.3	30	66.7	45	100.0	21.5
C44	Other skin	264	58	22.0	206	78.0	264	100.0	32.2
C47+C49	Connective tissue	135	46	34.1	89	65.9	135	100.0	28.9
C48	Peritoneum	54	36	66.7	18	33.3	54	100.0	19.3
C50	Breast	1445	201	13.9	1244	86.1	1445	100.0	34.3
C53	Cervix	1298	234	18.0	1064	82.0	1298	100.0	38.4
C54	Corpus uteri	140	23	16.4	117	83.6	140	100.0	34.5
C55	Uterus unspecified	33	23	69.7	10	30.3	33	100.0	0.9
C56	Ovary	390	119	30.5	271	69.5	390	100.0	32.8
C61	Prostate	282	96	34.0	186	66.0	282	100.0	25.1
C62	Testis	29	1	3.4	28	96.6	29	100.0	39.5
C64	Kidney	279	86	30.8	193	69.2	279	100.0	27.5
C65	Renal pelvis	34	12	35.3	22	64.7	34	100.0	25.5
C66	Ureter	33	9	27.3	24	72.7	33	100.0	26.3
C67	Urinary bladder	467	134	28.7	333	71.3	467	100.0	30.2
C70-72	Brain & nervous system	333	171	51.4	162	48.6	333	100.0	19.6
C73	Thyroid	712	49	6.9	663	93.1	712	100.0	41.0
C74	Adrenal gland	30	11	36.7	19	63.3	30	100.0	25.3
C81	Hodgkin lymphoma	28	5	17.9	23	82.1	28	100.0	43.9
C82-85+C96	Non-Hodgkin lymphoma	483	220	45.5	263	54.5	483	100.0	22.5
C90	Multiple myeloma	89	57	64.0	32	36.0	89	100.0	15.4
C91	Lymphoid leukaemia	125	58	46.4	67	53.6	125	100.0	20.4
C92-94	Myeloid leukaemia	250	143	57.2	107	42.8	250	100.0	18.0

Other tables available for this registry:

- Table1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Incheon, South Korea, 1997-2001 cases followed-up until 2002)
- Table2b:	Number and proportion of cases by vital status and median follow-up (in months) by site (Incheon, Korea, 1997-2001 cases followed-up until 2002)
- Table3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Incheon, South Korea, 1997-2001 cases followed-up until 2002)
- Table4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Incheon, South Korea, 1997-2001 cases followed-up until 2002)

Registry chapter:

Consult the chapter in Cancer survival in developping countries (Volume II)